Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schmierer

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Neuropathology and Applied Neurobiology|November 26, 2003
Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brainK Schmierer, F Scaravilli, G J Barker, et al.
Neurology|July 23, 1998
Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppressionK Schmierer, J M Valdueza, A Bender, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2019
Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing SchemeG Giovannoni, P A Brex, D Dhiraj, et al.
Journal of Neurology|October 9, 2013
Progressive ataxia with oculo-palatal tremor and optic atrophyM M Papachatzaki, N Ali, Q Arshad, et al.
Eneurologicalsci|November 9, 2020
Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?M Mateo-Casas, S Reyes, S De Trane, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Disease activity in progressive multiple sclerosis can be effectively reduced by cladribineO Yildiz, Z Mao, A Adams, et al.
Clinical and Experimental Immunology|July 17, 2020
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseasesD Baker, C A K Roberts, G Pryce, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosisD R Altmann, T Button, K Schmierer, et al.
Multiple Sclerosis and Related Disorders|October 22, 2023
Anaesthetic management of people with multiple sclerosisN Dubuisson, O de Maere d'Aertrijcke, M Marta, et al.
Neurology|May 22, 2009
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRIR A Farrell, D Antony, G R Wall, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Neuropathology and Applied Neurobiology|November 26, 2003
Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brainK Schmierer, F Scaravilli, G J Barker, et al.
Neurology|July 23, 1998
Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppressionK Schmierer, J M Valdueza, A Bender, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2019
Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing SchemeG Giovannoni, P A Brex, D Dhiraj, et al.
Journal of Neurology|October 9, 2013
Progressive ataxia with oculo-palatal tremor and optic atrophyM M Papachatzaki, N Ali, Q Arshad, et al.
Eneurologicalsci|November 9, 2020
Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?M Mateo-Casas, S Reyes, S De Trane, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Disease activity in progressive multiple sclerosis can be effectively reduced by cladribineO Yildiz, Z Mao, A Adams, et al.
Clinical and Experimental Immunology|July 17, 2020
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseasesD Baker, C A K Roberts, G Pryce, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosisD R Altmann, T Button, K Schmierer, et al.
Multiple Sclerosis and Related Disorders|October 22, 2023
Anaesthetic management of people with multiple sclerosisN Dubuisson, O de Maere d'Aertrijcke, M Marta, et al.
Neurology|May 22, 2009
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRIR A Farrell, D Antony, G R Wall, et al.
Pageof 5